- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
medmix AG (MEDX)
medmix AG stock price live, this page displays SIX MEDX stock exchange data. View the MEDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the medmix AG real time stock price chart below.
What Is the medmix AG Stock Price Today?
The medmix AG stock price today is 11.98.
What Is the Stock Symbol for medmix AG?
The stock symbol for medmix AG is "MEDX."
What Stock Exchange Does medmix AG Trade On?
medmix AG is listed and trades on the Switzerland stock exchange.
Is medmix AG a Good Stock to Buy?
Determining whether medmix AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDX quote. (ISIN: CH1129677105)
What Is the medmix AG Stock Price Today?
The medmix AG stock price today is 11.98.
What Is the Stock Symbol for medmix AG?
The stock symbol for medmix AG is "MEDX."
What Stock Exchange Does medmix AG Trade On?
medmix AG is listed and trades on the Switzerland stock exchange.
Is medmix AG a Good Stock to Buy?
Determining whether medmix AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDX quote. (ISIN: CH1129677105)
Switzerland
Currency in CHF
11.98
-0.08(-0.66%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.82
12.02
52 wk Range
8.18
13.72
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.8212.02
52 wk Range
8.1813.72
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.17%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.17%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MEDX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
17.50
Upside
+46.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- medmix AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - medmix receives Investment Bank Analyst Rating Update
- Investing.com
Pro - medmix AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - medmix receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- medmix receives Investment Bank Analyst Rating Update
- Investing.com
Pro - medmix receives Investment Bank Analyst Rating Update
- Investing.com
Pro - medmix AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Medmix AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
medmix AG Company Profile
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company offers dental products, including mixing tips and cartridges for various applications, such as prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and general industrial industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. medmix AG was founded in 1922 and is based in Baar, Switzerland.
Compare MEDX to Peers and Sector
Metrics to compare | MEDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −84.3x | 18.0x | −0.6x | |
PEG Ratio | 0.38 | 0.12 | 0.00 | |
Price/Book | 1.2x | 3.1x | 2.6x | |
Price / LTM Sales | 1.0x | 2.1x | 3.4x | |
Upside (Analyst Target) | 50.3% | 18.7% | 41.1% | |
Fair Value Upside | Unlock | 8.1% | 5.3% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.50
(+46.08% Upside)
Earnings
Latest Release
Jul 22, 2025
EPS / Forecast
0.16 / --
Revenue / Forecast
225.40M / --
People Also Watch
FAQ
What Is the medmix (MEDX) Stock Price Today?
The medmix stock price today is 11.98
What Stock Exchange Does medmix Trade On?
medmix is listed and trades on the Switzerland Stock Exchange stock exchange.
What Is the Stock Symbol for medmix?
The stock symbol for medmix is "MEDX."
Does medmix Pay Dividends? What’s The Current Dividend Yield?
The medmix dividend yield is 4.17%.
What Is the medmix Market Cap?
As of today, medmix market cap is 489.02M.
What Is medmix's Earnings Per Share (TTM)?
The medmix EPS (TTM) is -0.14.
From a Technical Analysis Perspective, Is MEDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has medmix Stock Split?
medmix has split 0 times.
How Many Employees Does medmix Have?
medmix has 2667 employees.
What is the current trading status of medmix (MEDX)?
As of Jan 19, 2026, medmix (MEDX) is trading at a price of 11.98, with a previous close of 12.06. The stock has fluctuated within a day range of 11.82 to 12.02, while its 52-week range spans from 8.18 to 13.72.
What Is medmix (MEDX) Price Target According to Analysts?
The average 12-month price target for medmix is CHF17.5, with a high estimate of CHF20 and a low estimate of CHF14.5. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +46.08% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.